| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/22/2006 | WO2006066163A1 Quantum dot-encoded bead set for calibration and quantification of multiplexed assays, and methods for their use |
| 06/22/2006 | WO2006066123A1 Disposable test sensor cartridge |
| 06/22/2006 | WO2006066038A2 Analyte test device having a trend-indicating display |
| 06/22/2006 | WO2006065943A2 In-vivo monitoring of circulating apoptotic cells |
| 06/22/2006 | WO2006065940A2 Identification and use of prognostic and predictive markers in cancer treatment |
| 06/22/2006 | WO2006065912A1 Quantitative evaluation of emulsion stability based on critical electric field measurements |
| 06/22/2006 | WO2006065901A1 Multi-contact connector assembly for a sensor-dispensing instrument |
| 06/22/2006 | WO2006065899A1 A method of differentiating between blood and control solutions containing a common analyte |
| 06/22/2006 | WO2006065898A1 Transmission spectroscopy system for use in the determination of analytes in body fluid |
| 06/22/2006 | WO2006065802A2 Automated immunoassay cassette, apparatus and method |
| 06/22/2006 | WO2006065762A2 Surface enhanced raman spectroscopy using shaped gold nanoparticles |
| 06/22/2006 | WO2006065754A2 Sensor-dispensing instruments |
| 06/22/2006 | WO2006065709A2 Functional assays for cholesterol absorption inhibitors |
| 06/22/2006 | WO2006065702A1 Marker for readings taken from alternative site tests |
| 06/22/2006 | WO2006065613A2 Methods for identifying t cell activation-modulating compounds |
| 06/22/2006 | WO2006065604A1 Systems and methods for characterizing kidney disseases |
| 06/22/2006 | WO2006065314A1 Sample-efficient lateral flow immunoassay |
| 06/22/2006 | WO2006065125A1 Means and methods for determining and/or influencing transportation |
| 06/22/2006 | WO2006065118A2 Chromatographic analyse-devices and test kits |
| 06/22/2006 | WO2006064983A1 Monoclonal antibody specific human embryonic stem cell |
| 06/22/2006 | WO2006064978A1 Extractant solution for residual veterinary agent in livestock product or seafood |
| 06/22/2006 | WO2006064864A1 Method of assessing cancerous conditions and reagent for detecting gene product to be used in the method |
| 06/22/2006 | WO2006064861A1 Function inhibitor of adam10 or adam17 protein and method of screening the same |
| 06/22/2006 | WO2006064844A1 Drug for diagnosing colon cancer and/or colon polyp, observing postoperative course and monitoring reoccurrence |
| 06/22/2006 | WO2006064819A1 Method of diagnosing disease caused by morphological change in protein by using the neutron scattering method |
| 06/22/2006 | WO2006064807A1 Method of pretreating specimen and immunoassay method using the same |
| 06/22/2006 | WO2006064745A1 Method of identifying nucleotide polymorphisms |
| 06/22/2006 | WO2006064739A1 Method of treating biological sample for performing nucleic acid amplification |
| 06/22/2006 | WO2006064639A1 Titanium-binding ferritin and method of arraying inorganic particle |
| 06/22/2006 | WO2006064631A1 Method, program and system for the standardization of gene expression amount |
| 06/22/2006 | WO2006064591A1 Substrate and method of quantifying target substance |
| 06/22/2006 | WO2006064488A1 A kit for colorimetric assays of food and beverage analytes |
| 06/22/2006 | WO2006064376A1 Peptides for treating retrovirus infection |
| 06/22/2006 | WO2006064372A2 Method for identifying modulators of the activity of ion-channels receptors |
| 06/22/2006 | WO2006064273A1 Assay |
| 06/22/2006 | WO2006064266A1 Moisture content sensor and related methods |
| 06/22/2006 | WO2006064197A2 Transgenic animals for assessing drug metabolism and toxicity |
| 06/22/2006 | WO2006064176A1 Assays for superantigens |
| 06/22/2006 | WO2006064115A1 USE OF NUCLEOTIDE SEQUENCES PREFERABLY INTERACTING WITH THE TRANSCRIPTION COMPLEX PPAR α |
| 06/22/2006 | WO2006064072A1 Peptides, nucleotide sequences and cnalinker13 cells and applications thereof |
| 06/22/2006 | WO2006064064A1 Method for diagnosing hepatic diseases |
| 06/22/2006 | WO2006064007A1 Transgenic animal models for neurodevelopmental disorders |
| 06/22/2006 | WO2006063844A1 Soluble hla-e molecules and their use for diagnosing and treating pathologies |
| 06/22/2006 | WO2006063800A1 Cloning of honey bee allergen |
| 06/22/2006 | WO2006063789A1 System for determining blood coagulation parameters |
| 06/22/2006 | WO2006063736A1 Cd31 antigen as target/marker for insulin resistance |
| 06/22/2006 | WO2006063735A1 Endoglin as target/marker for insulin resistance |
| 06/22/2006 | WO2006063734A2 Integrin (alpha v beta 1) as target/marker for insulin resistance |
| 06/22/2006 | WO2006063733A1 Cd99 as target/marker for insulin resistance |
| 06/22/2006 | WO2006063717A2 Polymerase-independent analysis of the sequence of polynucleotides |
| 06/22/2006 | WO2006063704A2 Single nucleotide polymorphism (snp) associated to type ii diabetes |
| 06/22/2006 | WO2006063703A2 Single nucleotide polymorphism (snp) associated to type ii diabetes |
| 06/22/2006 | WO2006063685A1 Appliance for testing the fracture resistance of tablets |
| 06/22/2006 | WO2006063527A1 Adjustable molecular motor micropower biosensor and its application |
| 06/22/2006 | WO2006063518A1 Multifunctional polypeptides |
| 06/22/2006 | WO2006063462A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 06/22/2006 | WO2006063452A1 Ex vivo verification of biopsy tissue samples |
| 06/22/2006 | WO2006063437A1 Prion sensors for diagnosis of transmissible spongiform encephalopathy or for detection of prions, and use thereof |
| 06/22/2006 | WO2006061414A1 Methods and agents useful in treating conditions characterized by mucus hyperproduction/ hypersecretion |
| 06/22/2006 | WO2006044896A3 Fluid processing device including composite material flow modulator |
| 06/22/2006 | WO2006044413A3 Methods for forming dyed microspheres and populations of dyed microspheres |
| 06/22/2006 | WO2006040047A3 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 06/22/2006 | WO2006034417A3 Trivalent metal mediated homogeneous luminescent proximity assay |
| 06/22/2006 | WO2006034356A9 Cardiac pressure overload associated genes |
| 06/22/2006 | WO2006034232A3 Diagnostic marker |
| 06/22/2006 | WO2006031155A3 Identification of explosives by frequency domain microwave spectroscopy in reflection mode |
| 06/22/2006 | WO2006029719A3 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 1, group h, member 4 (nr1h4) |
| 06/22/2006 | WO2006027702A3 Analyte detecting member with a 3d hydrogel |
| 06/22/2006 | WO2006027701A3 Fas associated factor 1 |
| 06/22/2006 | WO2006024449A3 Diagnostics and therapeutics for diseases associated with cysteinyl leukotriene receptor 1 (cyslt1) |
| 06/22/2006 | WO2006014958A3 Platelet activation markers as predictors of disease and of response to therapy and for monitoring therapeutic progress |
| 06/22/2006 | WO2006012415A3 Rage protein derivatives |
| 06/22/2006 | WO2006010805A3 Novel polypeptides for isolating in vitro and preventing legionella pneumophila infections |
| 06/22/2006 | WO2006010514A3 Diagnostics and therapeutics for diseases associated with dual specificity mitogen-activated protein kinase kinase 5 (map2k5) |
| 06/22/2006 | WO2006010498A3 Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 2 (metap2) |
| 06/22/2006 | WO2006008008A3 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| 06/22/2006 | WO2006007450A3 Detection, evaluation and treatment for advanced prostate cancer |
| 06/22/2006 | WO2005118633A3 Electrical conductors and devices from prion-like proteins |
| 06/22/2006 | WO2005117996A3 Immune response assessment method |
| 06/22/2006 | WO2005116185A3 Binding assay device with reservoir |
| 06/22/2006 | WO2005108626A3 Mutants of staphylococcal mrs and methods of use |
| 06/22/2006 | WO2005106497A3 Led bonding structures and methods of fabricating led bonding structures |
| 06/22/2006 | WO2005101004A8 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 06/22/2006 | WO2005095953A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor type 6 (ccr6) |
| 06/22/2006 | WO2005089454A3 Fluorescence polarization assay |
| 06/22/2006 | WO2005085867A8 Screening method for emulators of neural activity and digestive system using gpr35 |
| 06/22/2006 | WO2005074381A3 Induction of apoptosis via arts-iap complexes |
| 06/22/2006 | WO2005062955A3 Agonist anti-trkc antibodies and methods using same |
| 06/22/2006 | WO2005027716A3 Program for regulating health conditions |
| 06/22/2006 | WO2005026687A3 Diagnosis and monitoring of hepatocellular carcinoma |
| 06/22/2006 | WO2005021709A9 Cln101 antibodies |
| 06/22/2006 | WO2005005957A3 Method of detecting cancer using delta-catenin |
| 06/22/2006 | WO2004101738A3 Domain-exchanged binding molecules, methods of use and methods of production |
| 06/22/2006 | US20060137029 Novel G protein-coupled receptor encoding gene and diagnostic uses therefor |
| 06/22/2006 | US20060136186 Modular computational models for predicting the pharmaceutical properties of chemical compounds |
| 06/22/2006 | US20060136161 Method and system for real time reporting of boiler adjustment using emission sensor data mapping |
| 06/22/2006 | US20060136148 Efficient algorithm for PCR testing of blood samples |
| 06/22/2006 | US20060136147 Biological relationship event extraction system and method for processing biological information |
| 06/22/2006 | US20060136146 Modulators of ribosomal function and identification thereof |
| 06/22/2006 | US20060136142 Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA |